CompletedNot Applicable

Analysis of Spatiotemporal Gait Parameters in Patients With Megaprosthesis.

Spain79 participantsStarted 2018-02-08

Plain-language summary

The main objective of the study is to evaluate spatiotemporal parameters of gait in tumoral patients with megaprosthesis of the distal femur.

Who can participate

Age range16 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Megaprosthesis of the distal femur * Tumor cause * Surgery at Hospital la Fe. * Traditional stem or biological ossteointegration system * Minimum postoperative follow-up period of 3 months Exclusion Criteria: * Neurological alterations prior to the intervention that affect the lower limbs or general movement. * Patient incapable of ambulation due to progression of his/her pathology * Patient at home with palliative treatment for advanced tumor disease * Any ipsilateral or contralateral prosthesis. * Infectious or traumatic cause

What they're measuring

Antero-posterior acceleration symmetry index

Timeframe: 3 months

Stance Phase

Timeframe: 3 months

Swing Phase

Timeframe: 3 months

Gait Quality Index

Timeframe: 3 months

First Double support phase

Timeframe: 3 months

Single Support Phase

Timeframe: 3 months

Propulsion Index

Timeframe: 3 months

Pelvic tilt range

Timeframe: 3 months

Pelvic obliquity range

Timeframe: 3 months

Trial details

NCT IDNCT05202873

SponsorCardenal Herrera University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-11-01

View on ClinicalTrials.gov More Distal Femoral Musculoskeletal Tumors trials